Found: 64
Select item for more details and to access through your institution.
PI3K pathway protein analyses in metastatic breast cancer patients receiving standard everolimus and exemestane.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 11, p. 3013, doi. 10.1007/s00432-020-03291-x
- By:
- Publication type:
- Article
Contralateral parenchymal enhancement on breast MRI before and during neoadjuvant endocrine therapy in relation to the preoperative endocrine prognostic index.
- Published in:
- European Radiology, 2020, v. 30, n. 12, p. 6740, doi. 10.1007/s00330-020-07058-3
- By:
- Publication type:
- Article
Tailored Tamoxifen Treatment for Breast Cancer Patients: A Perspective.
- Published in:
- Clinical Breast Cancer, 2015, v. 15, n. 4, p. 241, doi. 10.1016/j.clbc.2015.04.005
- By:
- Publication type:
- Article
Concurrent versus sequential use of trastuzumab and chemotherapy in early HER2+ breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 185, n. 3, p. 817, doi. 10.1007/s10549-020-05978-8
- By:
- Publication type:
- Article
Breast cancer outcome in relation to bone mineral density and bisphosphonate use: a sub-study of the DATA trial.
- Published in:
- Breast Cancer Research & Treatment, 2020, v. 180, n. 3, p. 675, doi. 10.1007/s10549-020-05567-9
- By:
- Publication type:
- Article
Dissecting the predictive value of MAPK/AKT/estrogen-receptor phosphorylation axis in primary breast cancer to treatment response for tamoxifen over exemestane: a Translational Report of the Intergroup Exemestane Study (IES)—PathIES.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 175, n. 1, p. 149, doi. 10.1007/s10549-018-05110-x
- By:
- Publication type:
- Article
Unexpected toxicity of CDK4/6 inhibitor palbociclib and radiotherapy.
- Published in:
- Cancer Reports, 2022, v. 5, n. 2, p. 1, doi. 10.1002/cnr2.1470
- By:
- Publication type:
- Article
Hierarchical clustering of PI3K and MAPK pathway proteins in breast cancer intrinsic subtypes.
- Published in:
- APMIS, 2020, v. 128, n. 4, p. 298, doi. 10.1111/apm.13026
- By:
- Publication type:
- Article
Expression of drug resistance proteins in breast cancer, in relation to chemotherapy.
- Published in:
- International Journal of Cancer, 1997, v. 71, n. 5, p. 787, doi. 10.1002/(SICI)1097-0215(19970529)71:5<787::AID-IJC16>3.0.CO;2-5
- By:
- Publication type:
- Article
Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: Cross-sectional findings from the neuropsychological TEAM-side study.
- Published in:
- Acta Oncologica, 2009, v. 48, n. 1, p. 76, doi. 10.1080/02841860802314738
- By:
- Publication type:
- Article
Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging.
- Published in:
- Human Brain Mapping, 2012, v. 33, n. 12, p. 2971, doi. 10.1002/hbm.21422
- By:
- Publication type:
- Article
Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer.
- Published in:
- Journal of Pathology, 2009, v. 218, n. 3, p. 316, doi. 10.1002/path.2544
- By:
- Publication type:
- Article
BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Lack of Genomic Heterogeneity at High-Resolution aCGH between Primary Breast Cancers and Their Paired Lymph Node Metastases.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0103177
- By:
- Publication type:
- Article
The impact of different definitions and reference groups on the prevalence of cognitive impairment: a study in postmenopausal breast cancer patients before the start of adjuvant systemic therapy.
- Published in:
- Psycho-Oncology, 2010, v. 19, n. 4, p. 415, doi. 10.1002/pon.1595
- By:
- Publication type:
- Article
The prognostic and predictive effect of body mass index in hormone receptor-positive breast cancer.
- Published in:
- JNCI Cancer Spectrum, 2023, v. 7, n. 6, p. 1, doi. 10.1093/jncics/pkad092
- By:
- Publication type:
- Article
Characterization of Oligometastatic Disease in a Real-World Nationwide Cohort of 3447 Patients With de Novo Metastatic Breast Cancer.
- Published in:
- JNCI Cancer Spectrum, 2021, v. 5, n. 3, p. 1, doi. 10.1093/jncics/pkab010
- By:
- Publication type:
- Article
IHC-based Ki67 as response biomarker to tamoxifen in breast cancer window trials enrolling premenopausal women.
- Published in:
- NPJ Breast Cancer, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41523-021-00344-3
- By:
- Publication type:
- Article
Constructive Technology Assessment (CTA) as a tool in Coverage with Evidence Development: The case of the 70-gene prognosis signature for breast cancer diagnostics.
- Published in:
- International Journal of Technology Assessment in Health Care, 2009, v. 25, n. 1, p. 73, doi. 10.1017/S0266462309090102
- By:
- Publication type:
- Article
Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene.
- Published in:
- Oncogene, 2001, v. 20, n. 45, p. 6551, doi. 10.1038/sj.onc.1204837
- By:
- Publication type:
- Article
Cancer-immune interactions in ER-positive breast cancers: PI3K pathway alterations and tumor-infiltrating lymphocytes.
- Published in:
- 2019
- By:
- Publication type:
- journal article
FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome.
- Published in:
- Molecular Oncology, 2018, v. 12, n. 11, p. 1884, doi. 10.1002/1878-0261.12353
- By:
- Publication type:
- Article
High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation.
- Published in:
- BMC Cancer, 2023, p. 1, doi. 10.1186/s12885-022-10412-x
- By:
- Publication type:
- Article
Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Reply to: Comments on "Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial".
- Published in:
- International Journal of Cancer, 2022, v. 151, n. 11, p. 2057, doi. 10.1002/ijc.34219
- By:
- Publication type:
- Article
Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy.
- Published in:
- Breast Cancer Research, 2014, v. 16, n. 3, p. 1, doi. 10.1186/bcr3655
- By:
- Publication type:
- Article
Genomic patterns resembling BRCA1- and BRCA2-mutated breast cancers predict benefit of intensified carboplatin-based chemotherapy.
- Published in:
- 2014
- By:
- Publication type:
- journal article
PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2 and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients.
- Published in:
- Breast Cancer Research, 2014, v. 16, n. 1, p. 1, doi. 10.1186/bcr3606
- By:
- Publication type:
- Article
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.
- Published in:
- Breast Cancer Research, 2014, v. 16, n. 1, p. 1, doi. 10.1186/bcr3598
- By:
- Publication type:
- Article
PIK3CA mutations, phosphatase and tensin homolog, human epidermal growth factor receptor 2, and insulin-like growth factor 1 receptor and adjuvant tamoxifen resistance in postmenopausal breast cancer patients.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Phosphorylated p-70S6K predicts tamoxifen resistance in postmenopausal breast cancer patients randomized between adjuvant tamoxifen versus no systemic treatment.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Scenario drafting to anticipate future developments in technology assessment.
- Published in:
- BMC Research Notes, 2012, v. 5, n. 1, p. 442, doi. 10.1186/1756-0500-5-442
- By:
- Publication type:
- Article
Risk-Adjusted Cancer Screening and Prevention (RiskAP): Complementing Screening for Early Disease Detection by a Learning Screening Based on Risk Factors.
- Published in:
- Breast Care, 2022, v. 17, n. 2, p. 208, doi. 10.1159/000517182
- By:
- Publication type:
- Article
Carboplatin-Cyclophosphamide or Paclitaxel without or with Bevacizumab as First-Line Treatment for Metastatic Triple-Negative Breast Cancer (BOOG 2013-01).
- Published in:
- Breast Care, 2021, v. 16, n. 6, p. 598, doi. 10.1159/000512200
- By:
- Publication type:
- Article
Hierarchical clustering of activated proteins in the PI3K and MAPK pathways in ER-positive, HER2-negative breast cancer with potential therapeutic consequences.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 4, p. e245552, doi. 10.1001/jamanetworkopen.2024.5552
- By:
- Publication type:
- Article
A Phase I dose‐escalation study of two cycles carboplatin‐olaparib followed by olaparib monotherapy in patients with advanced cancer.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 12, p. 3041, doi. 10.1002/ijc.33498
- By:
- Publication type:
- Article
IGF‐1R pathway activation as putative biomarker for linsitinib therapy to revert tamoxifen resistance in ER‐positive breast cancer.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 8, p. 2348, doi. 10.1002/ijc.32668
- By:
- Publication type:
- Article
Assessment and management of bone health in women with early breast cancer receiving endocrine treatment in the DATA study.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 5, p. 1325, doi. 10.1002/ijc.32205
- By:
- Publication type:
- Article
Efficacy of anastrozole after tamoxifen in early breast cancer patients with chemotherapy‐induced ovarian function failure.
- Published in:
- International Journal of Cancer, 2019, v. 145, n. 1, p. 274, doi. 10.1002/ijc.32093
- By:
- Publication type:
- Article
BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial.
- Published in:
- International Journal of Cancer, 2016, v. 139, n. 4, p. 882, doi. 10.1002/ijc.30078
- By:
- Publication type:
- Article
PI3K/AKT/mTOR pathway activation in primary and corresponding metastatic breast tumors after adjuvant endocrine therapy.
- Published in:
- International Journal of Cancer, 2014, v. 135, n. 5, p. 1257, doi. 10.1002/ijc.28769
- By:
- Publication type:
- Article
A phase I followed by a randomized phase II trial of two cycles carboplatin-olaparib followed by olaparib monotherapy versus capecitabine in BRCA1- or BRCA2-mutated HER2-negative advanced breast cancer as first line treatment (REVIVAL): study protocol for a randomized controlled trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Genomic instability in breast and ovarian cancers: translation into clinical predictive biomarkers.
- Published in:
- Cellular & Molecular Life Sciences, 2012, v. 69, n. 2, p. 223, doi. 10.1007/s00018-011-0809-0
- By:
- Publication type:
- Article
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage triple-negative breast cancer patients.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Identifying the BRCA1 c.-107A > T variant in Dutch patients with a tumor BRCA1 promoter hypermethylation.
- Published in:
- Familial Cancer, 2023, v. 22, n. 2, p. 151, doi. 10.1007/s10689-022-00314-z
- By:
- Publication type:
- Article
Copy number profiling by array comparative genomic hybridization identifies frequently occurring BRCA2-like male breast cancer.
- Published in:
- Genes, Chromosomes & Cancer, 2015, v. 54, n. 12, p. 734, doi. 10.1002/gcc.22284
- By:
- Publication type:
- Article
Paclitaxel, Carboplatin, and Trastuzumab in a Neo-adjuvant Regimen for HER2-positive Breast Cancer.
- Published in:
- Breast Journal, 2013, v. 19, n. 4, p. 419, doi. 10.1111/tbj.12124
- By:
- Publication type:
- Article
PARP Inhibitors in the Treatment of Triple-Negative Breast Cancer.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Characterizing steroid hormone receptor chromatin binding landscapes in male and female breast cancer.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-02856-2
- By:
- Publication type:
- Article